We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avalon Pharmaceuticals (MM) | NASDAQ:AVRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.59 | 0 | 01:00:00 |
Delaware | 001-32629 | 52-2209310 | ||
(State or other | (Commission File | (I.R.S. Employer | ||
jurisdiction of | Number) | Identification No.) | ||
incorporation or | ||||
organization) |
20358 Seneca Meadows Parkway, | ||||
Germantown, Maryland | 20876 | |||
(Address of principal executive offices) | (Zip Code) |
þ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
99.1 | Press release dated December 22, 2008. |
Avalon Pharmaceuticals, Inc.
|
||||
Date: December 22, 2008 | By: | /s/ C. Eric Winzer | ||
C. Eric Winzer | ||||
Executive Vice President and
Chief Financial Officer |
||||
1 Year Avalon Chart |
1 Month Avalon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions